IMPACT Therapeutics Licenses Senaparib to Pharmanovia
SHANGHAI, July 31, 2026 IMPACT Therapeutics announced an exclusive licensing agreement with Pharmanovia, granting the global specialty pharmaceutical company...
Licensing Agreement
Advertisement
Kaigene, Taisho Advance KG006 Autoimmune Therapy Deal
ROCKVILLE, Md. and TOKYO, July 30, 2026 Kaigene has entered into an exclusive licensing agreement with Taisho Pharmaceutical Co.,...
Innovent, Spero Sign $1.1B IBI355 Global Licensing Deal
SAN FRANCISCO, Calif., CAMBRIDGE, Mass., & SUZHOU, China, July 14, 2026 Innovent Biologics and Spero Therapeutics have entered into...
Ocugen Signs OCU400 Licensing Agreement with Roots Pharma
MALVERN, Pa., July 13, 2026 Ocugen announced the signing of a binding term sheet with Roots Pharmaceutical and its...
Sino Biopharm Secures $2.1B TQC3721 AstraZeneca Agreement
HONG KONG, July 8, 2026 Sino Biopharmaceutical Limited has announced that its subsidiary, Chia Tai Tianqing Pharmaceutical Group Co.,...
Advertisements
Aligos Secures $25M Upfront in Greater China Deal
SOUTH SAN FRANCISCO, Calif., July 6, 2026 Aligos Therapeutics has received a $25 million upfront payment from Xiamen Amoytop...
Junshi Biosciences Expands Roconkibart Through Fosun Alliance
Shanghai, China, July 1, 2026 Junshi Biosciences has entered into a landmark licensing collaboration with Fosun Wanbang Pharma Group,...
LENZ Therapeutics Partners Arrotex to Launch VIZZ in ANZ
SAN DIEGO & MELBOURNE, Australia, June 24, 2026 LENZ Therapeutics has significantly expanded the international commercialization strategy for its...
Abbisko Therapeutics and Lilly Expand Global R&D Partnership
SHANGHAI, June 23, 2026 Abbisko Therapeutics Co., Ltd. announced a strategic research collaboration and license agreement with Eli Lilly...
AlzeCure and Eli Lilly Partner on Alzheimer’s Drug ACD680
STOCKHOLM, Sweden, June 9, 2026 AlzeCure Pharma announced a global collaboration and out-licensing agreement with Eli Lilly and Company...
Advertisement
